MSA Safety Incorporated (MSA)
NYSE: MSA · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Cranberry Township, PA
Our rating: Neutral
Neutral reaffirmed at $177.60, moderate conviction, November 4, 2026.
Breaks if: The Neutral call tilts Positive if MSA reports revenue growth above 7% for two consecutive quarters, implying genuine end-market acceleration that would begin to justify the current 25× multiple with room to expand. It tilts Cautious if net income margin falls below 12% for two consecutive quarters — a compression of that magnitude would strip the valuation support and leave the multiple without an earnings underpinning at current prices.
Key figures
| Market value | $6.5B |
|---|---|
| Revenue, last 12 months | $2.0B |
| Net income, last 12 months | $303M |
| Free cash flow, last 12 months | $322M |
| Price to earnings | 21.6× |
| Free cash flow yield | 4.9% |
| Dividend yield | 1.3% |
| Operating margin | 20.2% |
| Return on equity | 22.1% |
| Beta to the S&P 500 | 0.77 |
| Volatility, annualized | 24.2% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $536M | 14.5% | $1.51 | $68M |
| June 30, 2026 | $503M | 6.2% | $2.23 | $83M |
| March 31, 2026 | $464M | 10.0% | $1.83 | $65M |
| December 31, 2025 | $511M | 2.2% | $2.21 | $106M |
| September 30, 2025 | $468M | 8.3% | $1.77 | $100M |
| June 30, 2025 | $474M | 2.5% | $1.59 | $38M |
| March 31, 2025 | $421M | 1.9% | $1.51 | $51M |
| December 31, 2024 | $500M | 0.9% | $2.22 | $93M |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $0.55B: Claude 62%, Gemini 85%, Mistral 68%
- Diluted earnings per share are at least $2.21: Claude 55%, Gemini 90%, Mistral 58%
- Free cash flow for the quarter is at least $0.11B: Claude 45%, Gemini 60%, Mistral 42%
9 ledger entries and 37 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.